Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x100px
Organisation › Details

Mattern Pharmaceuticals AG

M et P owns a proprietary nasal drug delivery technology. Apart from the product Nasobol(r) and based on that technology, the Company develops drugs especially to improve Central Nervous System disorders. *

 

Period Start 1997-01-01 established
  Group Mattern Pharmaceuticals (M et P / M & P) (Group)
Products Industry respiratory drug delivery technology
  Industry 2 CNS drug (neurological drug)
     
Region Region Stans NW
  Country Switzerland
  Street 3 Mühlebachstr.
  City 6370 Stans NW
  Tel +41-41-618-3030
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: 
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top